All lobbying filings

INCYTE CORPORATION

Lobbying for INCYTE CORPORATION

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Delaware · House · Senate · $330,000.00 expenses · posted Oct 20, 2025

Official filing document

Bills named in this filing 3

HR 946
ORPHAN Cures Act
S 1862
ORPHAN Cures Act
HR 1262
Mikaela Naylon Give Kids a Chance Act

Lobbying activity 1

Medicare/Medicaid

H.R. 946/S. 1862, Orphan Cures Act implementation H.R. 1262 Give Kids a Chance Act Issues related to Medicaid rebates Issues related to Medicaid coverage of new drugs Issues related to implementation of the Inflation Reduction Act Issues related to the 340B Drug Pricing Program Issues related to drug cost and pricing Education around access to innovative therapies in dermatology

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.